Hematology Practice Questions

Q: What is the formula for parenteral iron therapy?

4.4 x body weight (kg) x Hb deficit (g/dL). The correct formula for calculating the total dose of parenteral iron required to restore hemoglobin levels and replenish iron stores is known as the **Ganzoni Formula**. ### 1. Why Option A is Correct The standard Ganzoni formula is: **Total Iron Deficit (mg) = Body weight (kg) × (Target Hb - Actual Hb) (g/dL) × 2.4 + Iron stores (mg)** In many simplified clinical calculations and exam-based questions, the factor **4.4** is used as a shorthand. This is derived from: * **2.4:** A constant representing the blood volume (approx. 7% of body weight) and the iron content of hemoglobin (0.34%). * **Iron Stores:** Usually estimated at 500 mg for adults. * When the iron store requirement is integrated into the multiplier for a standard adult weight, the coefficient effectively becomes **4.4**. This ensures both the hemoglobin deficit is corrected and the depleted stores are replenished. ### 2. Why Other Options are Incorrect * **Options B, C, and D:** These multipliers (3.3, 2.2, 1.1) are mathematically insufficient. Using these lower constants would result in under-replacement, correcting only the circulating hemoglobin without addressing the essential 500–1000 mg of storage iron (ferritin) required to prevent immediate recurrence of anemia. ### 3. NEET-PG High-Yield Pearls * **Target Hb:** Usually taken as 15 g/dL. * **Iron Stores:** If the body weight is >35 kg, stores are calculated as 500 mg. If <35 kg, stores are calculated as 15 mg/kg. * **Indication:** Parenteral iron is indicated in cases of oral iron intolerance, malabsorption (e.g., Celiac disease), or when rapid replenishment is needed (e.g., 3rd-trimester pregnancy or CKD). * **Adverse Effect:** While rare with newer formulations like Iron Sucrose or Ferric Carboxymaltose, always monitor for **anaphylaxis**.

Q: What is the best test for assessing iron status?

Ferritin. Explanation: **Serum Ferritin** is considered the most reliable and specific initial test for assessing total body iron stores. Ferritin is an intracellular protein that stores iron and releases it in a controlled manner; its serum levels are directly proportional to the total iron reserves in the reticuloendothelial system (liver, spleen, and bone marrow) [1]. In Iron Deficiency Anemia (IDA), a low serum ferritin level (<15–30 ng/mL) is the **earliest laboratory indicator** of depleted iron stores, often occurring before changes in hemoglobin or red cell indices [1]. **Analysis of Incorrect Options:** * **A. Transferrin:** This is a transport protein. While Total Iron Binding Capacity (TIBC) increases in IDA, it is an indirect measure and can be influenced by liver function and nutritional status. * **C. Serum Iron:** This measures iron bound to transferrin. It is subject to significant daily fluctuations (diurnal variation) and can be affected by recent dietary intake, making it an unreliable marker of overall status when used alone. * **D. Hemoglobin:** This is a marker of anemia, not iron status. Hemoglobin levels only drop during the final stage of iron deficiency (Iron Deficiency Anemia) after storage and transport iron are already exhausted. **Clinical Pearls for NEET-PG:** * **The "Gold Standard":** While Ferritin is the best *non-invasive* test, the **Prussian Blue stain of bone marrow aspirate** remains the definitive gold standard for assessing iron stores [1]. * **The Diagnostic Dilemma:** Ferritin is an **acute-phase reactant**. In the presence of inflammation, infection, or malignancy, ferritin levels may be falsely normal or elevated despite underlying iron deficiency. In such cases, a ferritin level <100 ng/mL may still suggest deficiency. * **Soluble Transferrin Receptor (sTfR):** This is a high-yield marker used to differentiate IDA (where sTfR is elevated) from Anemia of Chronic Disease (where sTfR is normal) [2].

Q: What is the most common manifestation of moderate/severe Hemophilia A?

Recurrent hemarthrosis. **Explanation:** Hemophilia A is an X-linked recessive disorder caused by a deficiency of **Clotting Factor VIII**. In moderate to severe cases (factor levels <5%), the hallmark of the disease is spontaneous or post-traumatic bleeding into deep tissues [1]. **1. Why Recurrent Hemarthrosis is Correct:** The most common and characteristic clinical manifestation of severe Hemophilia A is **hemarthrosis** (bleeding into joint spaces), accounting for nearly 75–80% of all bleeding episodes. The knees are the most frequently affected joints, followed by the elbows and ankles [1]. Repeated episodes lead to "Target Joints," eventually causing chronic synovial hypertrophy and **hemophilic arthropathy**, which is a major cause of morbidity [1]. **2. Why Other Options are Incorrect:** * **B. Recurrent muscle bleeding:** While hematomas in muscles (like the iliopsoas) are common in hemophilia, they occur less frequently than joint bleeds [1]. * **C. Recurrent bleeding from gums:** Mucosal bleeding (epistaxis, gum bleeding, menorrhagia) is more characteristic of **Platelet disorders** or **von Willebrand Disease**, rather than coagulation factor deficiencies. * **D. Recurrent hematuria:** Though spontaneous hematuria can occur in severe hemophiliacs, it is not the primary or most common presenting manifestation. **NEET-PG High-Yield Pearls:** * **Most common joint involved:** Knee joint [1]. * **Screening Test:** Prolonged aPTT; Normal PT and Bleeding Time. * **Confirmatory Test:** Specific Factor VIII assay. * **Treatment of Choice:** Recombinant Factor VIII concentrate [1]. * **Desmopressin (DDAVP):** Useful only in **Mild** Hemophilia A (releases stored Factor VIII from endothelial cells) [2].

Q: Pancytopenia with splenomegaly is seen in all of the following conditions EXCEPT:

Aplastic anemia. **Explanation:** The core clinical concept here is the relationship between bone marrow function and the spleen. **Pancytopenia** refers to a decrease in all three peripheral blood cell lines (RBCs, WBCs, and platelets). **1. Why Aplastic Anemia is the correct answer:** Aplastic anemia is characterized by primary bone marrow failure leading to a "dry tap" or hypocellular marrow. Crucially, **splenomegaly is characteristically absent** in aplastic anemia. If a patient with pancytopenia has a palpable spleen, the clinician must look for alternative diagnoses like leukemia or hypersplenism. **2. Analysis of Incorrect Options:** * **Myelofibrosis:** This condition involves marrow fibrosis leading to extramedullary hematopoiesis. The spleen takes over blood cell production, becoming massive (**massive splenomegaly**). While it starts with high counts, the "spent phase" results in pancytopenia. * **Hairy Cell Leukemia:** This is a classic "NEET-PG favorite." It presents with the triad of **pancytopenia, massive splenomegaly, and a dry tap** on marrow aspiration. * **Polycythemia Vera (Spent Phase):** While PV initially presents with erythrocytosis, it can progress to a "spent phase" (post-polycythemic myelofibrosis), where the marrow fails and the spleen enlarges significantly, leading to pancytopenia. **Clinical Pearls for NEET-PG:** * **Rule of Thumb:** Pancytopenia + Splenomegaly = Think of "Infiltration" or "Sequestration" (e.g., Leukemia, Gaucher disease, Kala-azar, Cirrhosis). * **Rule of Thumb:** Pancytopenia + NO Splenomegaly = Think of "Production Failure" (e.g., Aplastic anemia, PNH, Vitamin B12 deficiency). * **Hairy Cell Leukemia** is uniquely associated with **TRAP** (Tartrate-Resistant Acid Phosphatase) positivity and "hairy" projections on peripheral smear.

Q: A young female presented with iron deficiency anemia. Which of the following is FALSE?

Decreased TIBC. In Iron Deficiency Anemia (IDA), the body’s iron stores are depleted, leading to characteristic biochemical and hematological changes [1]. ### **Why Option B is False (The Correct Answer)** In IDA, **Total Iron Binding Capacity (TIBC) is INCREASED**, not decreased. TIBC is a functional measurement of Transferrin. When systemic iron levels are low, the liver increases the synthesis of Transferrin to maximize the transport of any available iron [1]. Therefore, an elevated TIBC is a classic compensatory finding in IDA. ### **Analysis of Other Options** * **A. Decreased Serum Ferritin:** This is the **earliest and most specific** biochemical marker of IDA. Ferritin reflects total body iron stores; low levels confirm deficiency. * **C. Microcytic Hypochromic Anemia:** As iron is essential for heme synthesis, its deficiency leads to smaller (Microcytic, Low MCV) and paler (Hypochromic, Low MCHC) red blood cells [1], [2]. * **D. Pica:** This is a classic clinical sign of IDA characterized by a craving for non-nutritive substances like ice (pagophagia), clay (geophagia), or starch. ### **NEET-PG High-Yield Pearls** * **Best Screening Test:** Serum Ferritin (decreased). * **Gold Standard Investigation:** Bone marrow aspiration (Perl’s Prussian Blue stain showing absent marrow iron). * **Transferrin Saturation:** Decreased (usually 13 suggests IDA; <13 suggests Thalassemia.

Q: All of the following features about Idiopathic Thrombocytopenia are true, EXCEPT:

Spontaneous remission is common in Chronic ITP. **Explanation:** Idiopathic Thrombocytopenic Purpura (ITP), now more commonly referred to as **Immune Thrombocytopenia**, is an acquired autoimmune disorder characterized by isolated thrombocytopenia (platelet count 12 months) rarely undergoes spontaneous remission. These patients often require long-term medical management (e.g., steroids, IVIg, or Rituximab) or surgical intervention (splenectomy). **Analysis of Other Options:** * **Option A:** Acute ITP in children is classically preceded by a **viral prodrome** (e.g., URI, varicella, or measles) or immunization 1–3 weeks before the onset of petechiae and bruising. * **Option B:** Chronic ITP shows a significant female predilection (Female:Male ratio of **3:1**), particularly in adolescents and adults, often associated with other autoimmune markers. * **Option D:** Acute ITP is the most common cause of sudden onset thrombocytopenia in an otherwise healthy child, typically peaking between **2–6 years of age**. **High-Yield Clinical Pearls for NEET-PG:** * **Diagnosis:** It is a diagnosis of exclusion. Bone marrow examination is not mandatory in classic pediatric cases but shows **increased megakaryocytes** if performed. * **Treatment Trigger:** In children, treatment is usually reserved for those with significant mucosal bleeding or a platelet count **<20,000/mm³**. * **First-line therapy:** Oral Prednisolone or IV Immunoglobulin (IVIg). * **Evans Syndrome:** ITP associated with Autoimmune Hemolytic Anemia (AIHA).

Q: Which condition is characterized by thrombocytopenia and widespread thrombosis?

Antiphospholipid antibody syndrome. **Explanation:** The correct answer is **Antiphospholipid Antibody Syndrome (APS)**. APS is an autoimmune prothrombotic state characterized by the presence of antiphospholipid antibodies (Lupus anticoagulant, Anticardiolipin, or Anti-β2 glycoprotein I). **Why Option A is correct:** The hallmark of APS is the "paradoxical" combination of **thrombosis** (both arterial and venous) and **thrombocytopenia** [1]. Thrombocytopenia occurs in approximately 20–40% of patients due to increased platelet consumption during thrombotic events or immune-mediated destruction of platelets coated with antibodies [1]. **Why the other options are incorrect:** * **B. Chronic Myeloid Leukemia (CML):** Typically presents with massive leukocytosis and **thrombocytosis** (elevated platelets), not thrombocytopenia. * **C. Hairy Cell Leukemia:** Characterized by pancytopenia (including thrombocytopenia) and massive splenomegaly, but it is not typically associated with widespread thrombosis. * **D. Hemolytic Uremic Syndrome (HUS):** While HUS involves thrombocytopenia and microvascular thrombosis, it is defined by a specific triad: Microangiopathic Hemolytic Anemia (MAHA), thrombocytopenia, and **acute kidney injury** [2]. APS is a more systemic condition involving large vessel thrombosis and obstetric complications. **NEET-PG High-Yield Pearls:** * **The APS Paradox:** Prolonged aPTT *in vitro* (due to antibody interference with phospholipids) but a hypercoagulable state *in vivo*. * **Obstetric APS:** Recurrent pregnancy loss (usually >10 weeks), premature births, or pre-eclampsia. * **Libman-Sacks Endocarditis:** Non-bacterial vegetative endocarditis associated with APS and SLE. * **Catastrophic APS (Asherson’s Syndrome):** Rapidly developing multiorgan failure due to small vessel occlusion.

Question 1

What is the formula for parenteral iron therapy?

Accepted Answer

4.4 x body weight (kg) x Hb deficit (g/dL)

Answer

3.3 x body weight (kg) x Hb deficit (g/dL)

Answer

2.2 x body weight (kg) x Hb deficit (g/dL)

Answer

1.1 x body weight (kg) x Hb deficit (g/dL)

Question 2

A 40-year-old female patient presents with leg swelling for one day, with no history of fever. Two years prior, she was treated for metastatic breast adenocarcinoma with paclitaxel and radiotherapy. Her vital signs are: Blood pressure 120/76 mmHg, Pulse rate 84/min, temperature 37.6 C, Respiratory rate 16/min, and oxygen saturation 99% on room air. Physical examination revealed warmth and tenderness over the left leg and thigh. Lung auscultation showed clear fields. A urine pregnancy test was negative, and CT chest was normal. Ultrasound of the left leg revealed a thrombus in the superficial femoral vein. What is the most appropriate treatment?

Accepted Answer

Enoxaparin and warfarin therapy with a goal to maintain an INR of 2-3

Answer

Dalteparin and enoxaparin together

Answer

Warfarin therapy with a goal to maintain an INR of 2-3

Answer

Aspirin and warfarin therapy with a goal to maintain an INR of 2-3

Question 3

What is the best test for assessing iron status?

Accepted Answer

Ferritin

Answer

Transferrin

Answer

Serum iron

Answer

Hemoglobin

Question 4

A 43-year-old woman complains of fatigue and night sweats associated with itching for 2 months. On physical examination, there is diffuse nontender lymphadenopathy, including small supraclavicular, epitrochlear, and scalene nodes. CBC and chemistry studies (including liver enzymes) are normal. Chest x-ray shows hilar lymphadenopathy. Which of the following is the best next step in evaluation?

Accepted Answer

Excisional lymph node biopsy

Answer

Monospot test

Answer

Toxoplasmosis IgG serology

Answer

Serum angiotensin-converting enzyme level

Question 5

What is the most common manifestation of moderate/severe Hemophilia A?

Accepted Answer

Recurrent hemarthrosis

Answer

Recurrent muscle bleeding

Answer

Recurrent bleeding from gums

Answer

Recurrent hematuria

Question 6

Plasmapheresis (plasma exchange therapy) is used in the treatment of which of the following conditions?

Accepted Answer

Thrombotic thrombocytopenic purpura

Answer

Autoimmune hemolytic anemia

Answer

Disseminated intravascular coagulation

Answer

Hemolytic uremic syndrome

Question 7

Pancytopenia with splenomegaly is seen in all of the following conditions EXCEPT:

Accepted Answer

Aplastic anemia

Answer

Myelofibrosis

Answer

Hairy cell leukemia

Answer

Polycythemia vera

Question 8

A young female presented with iron deficiency anemia. Which of the following is FALSE?

Accepted Answer

Decreased TIBC

Answer

Decreased serum ferritin

Answer

Microcytic hypochromic anemia

Answer

Pica

Question 9

All of the following features about Idiopathic Thrombocytopenia are true, EXCEPT:

Accepted Answer

Spontaneous remission is common in Chronic ITP

Answer

Acute ITP is often preceded by viral infections

Answer

Chronic ITP is common in females

Answer

Acute ITP is more common in children

Question 10

Which condition is characterized by thrombocytopenia and widespread thrombosis?

Accepted Answer

Antiphospholipid antibody syndrome

Answer

Chronic myeloid leukemia

Answer

Hairy cell leukemia

Answer

Hemolytic uremic syndrome

Hematology — MCQs

Hematology — MCQs

On this page

Practice by Chapter

Want unlimited practice?